The aim of the study was to evaluate the prevalence of high-risk HPV (HR-HPV) types among women with cervical intraepithelial neoplasia (CIN 2-3) and to evaluate the interest of high-risk HPV typing by hybrid capture 2 (HC2) in severe cervical dysplasias. ...
Inner border--a specific and significant colposcopic sign for moderate or severe dysplasia (cervical intraepithelial neoplasia 2 or 3). Inner border, a specific and significant colposcopic sign for moderate or severe dysplasia (cervical intraepithelial neoplasia 2 or 3). J Low Genit Tract... C ...
Patients were excluded if suffering from myelodysplasia or from a history of allergic reactions to components of chemical compositions similar to the oil used for optical coupling in our clinical device, or if their skin phototype was larger than four on the Fitzpatrick scale32. The MGH clinical ...
severe dysplasia, and carcinoma in situ); SCC: squamous cell carcinoma; ADCA: adenocarcinoma; ADSQCA: adenosquamous carcinoma; GCL 6: severely atypical glandular cell lesion; GCL 4: mildly atypical glandular cell lesion;
A method for treating the moderate and severe (CIN 2-3) dysplasia of the cervical epithelium caused by papillomavirus in the pregnant women comprises the elimination of the pathologic focus following the normalization of cervico-vaginal biocenosis by the topical application of iodine oxide. For de-...
Inner border -- a specific and significant colposcopic sign for moderate or severe dysplasia (cervical intraepithelial neoplasia 2 or 3). J Lower Genit Tract Dis. 2009; 13:1-4.Scheungraber C, Glutig K, Fechtel B, Kuehne-Heid R, Duerst M, Schneider A. Inner border--a specific ...
Study design: Five patients with histologically demonstrated severe cervical dysplasia (CIN3) HPV16 positive were injected three times before conization was performed 2 months after the first injection. We studied cytological, histological, proliferative pattern and immune profile before and after ...
HPV‐mRNA and HPV‐DNA detection in samples taken up to seven years before severe dysplasia of cervix uteridoi:10.1002/ijc.31819HPV‐mRNAHPV‐DNACINRandomized clinical trials using human papillomavirus (HPV) DNA testing have found increased protection against cervical cancer and HPV‐based screening ...
HPV-mRNA and HPV-DNA detection in samples taken up to seven years before severe dysplasia of cervix uteriHPV-mRNAHPV-DNACINRandomized clinical trials using human papillomavirus (HPV) DNA testing have found increased protection against cervical cancer and HPV-based screening is globally recommended for...
Almost half with positive margins followed at >1 year after initial LEEP had CIN2/3 recurrence warranting further treatment; two thirds were not followed. Resources are needed to improve post-LEEP follow-up for women with margin positivity who require additional ablative/excisional procedures to ...